TAS2R38 and rheumatoid arthritis: This population-based study was selected due to the fact that it has a large control group (N = 347; PAV/PAV 20%, PAV/AVI 51%, AVI/AVI 29%) from a similar region (North America) as our RA population and provided the frequencies of TAS2R38 genotypes among the groups, not only haplotypes.